首页> 美国卫生研究院文献>Cancer Medicine >The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy

【2h】

The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy

机译：空腹血糖对血清鳞状细胞癌抗原的附加价值用于预测接受新辅助化疗后行全子宫切除术的宫颈癌患者的肿瘤学结局

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo determine the combination of fasting blood glucose (FBG) with squamous cell carcinoma antigen (SCCA) assessments in the prediction of tumor responses to chemotherapy and pretreatment prognostication among patients receiving neoadjuvant chemotherapy (NACT) for locally advanced cervical cancer (LACC).

机译：目的确定空腹血糖（FBG）与鳞状细胞癌抗原（SCCA）评估相结合，以预测局部晚期宫颈癌（LACC）新辅助化疗（NACT）患者对化疗的肿瘤反应和预后。

著录项

期刊名称 Cancer Medicine
作者
Miao‐Fang Wu; Mei‐Mei Guan; Chang‐Hao Liu; Jie‐Ying Wu; Qun‐Xian Rao; Jing Li;
展开▼
作者单位

展开▼
年(卷),期 2019(8),11
年度 2019
页码 5068–5078
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
cervical cancer fasting blood glucose neoadjuvant chemotherapy prognosis squamous cell carcinoma antigen;

机译：宫颈癌;空腹血糖;新辅助化疗;预后;鳞状细胞癌抗原;

相似文献

外文文献
中文文献
专利

1. The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy [J] . Miao‐Fang Wu, Mei‐Mei Guan, Chang‐Hao Liu, Cancer Medicine . 2019,第11期

机译：血糖与血清鳞状细胞癌抗原的附加值，以预测接受Neoadjuvant化疗的宫颈癌患者肿瘤患者，其次是自由基子宫切除术
2. A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass [J] . Eriko Takatori, Tadahiro Shoji, Anna Takada, OncoTargets and therapy . 2016,第4期

机译：Ⅱ期宫颈鳞状细胞癌肿块患者新辅助化疗加根治性子宫切除术与单纯根治性子宫切除术的回顾性研究
3. Squamous cell carcinoma antigen expression in tumor cells is associated with the chemosensitivity and survival of patients with cervical cancer receiving docetaxel-carboplatin-based neoadjuvant chemotherapy [J] . Chen Peng, Jiao Liang, Wang Dan-Bo Oncology letters . 2017,第3aPta1期

机译：肿瘤细胞癌抗原在肿瘤细胞中表达与宫颈癌接受多西紫杉醇 - 卡铂的新辅助化疗的患者的化学敏感性和存活相关
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. The Predictive Value of Serum Squamous Cell Carcinoma Antigen in Patients with Cervical Cancer Who Receive Neoadjuvant Chemotherapy followed by Radical Surgery: A Single-Institute Study [O] . Xiong Li, Jin Zhou, Kecheng Huang, -1

机译：宫颈鳞状细胞癌抗原在接受新辅助化疗和根治性手术的宫颈癌患者中的预测价值：单机构研究
7. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study. [O] . Xiong Li, Jin Zhou, Kecheng Huang, 2015

机译：宫颈癌患者接受新辅助化疗和根治性手术后血清鳞状细胞癌抗原的预测价值：单研究。

The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy

摘要

著录项

相似文献

相关主题

期刊订阅